The effect of HIV components on lymphocytes, as exemplified by peripheral
blood mononuclear cells (PBMC) in retarding their proliferation can be
reversed by inhibiting the PKA/cAMP pathway. By using protocols which
inhibit this pathway, the ability of lymphocytes to proliferate can be
restored. The restoration of this pathway is useful in reversing the
effects of HIV infection.